Article info

Download PDFPDF

Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

Authors

  1. Correspondence to Dr Harinder Singh Chahal, US Food and Drug Administration ; harinder.chahal{at}fda.hhs.gov
View Full Text

Citation

Chahal HS, Capella P, Presto R, et al
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

Publication history

  • Received November 17, 2017
  • Revised February 28, 2018
  • Accepted March 1, 2018
  • First published May 17, 2018.
Online issue publication 
May 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.